Key result
Higher cumulative remnant cholesterol burden is linked to ~27% higher incident CVD risk.
Why the study?
Does higher cumulative exposure and variability of remnant cholesterol increase the risk of incident cardiovascular disease in adults?
Cohort (n=5,805)
Does higher cumulative exposure and variability of remnant cholesterol increase the risk of incident cardiovascular disease in adults?
Answers are grounded in this paper and cite their sources.
Long-term cumulative exposure and variability of remnant cholesterol are independently associated with increased risk of incident cardiovascular disease, suggesting their potential utility in early risk stratification.
Background Remnant cholesterol (RC) has emerged as an independent atherogenic factor, contributing to cardiovascular risk. However, the impact of long-term cumulative RC exposure and RC variability on the cardiovascular outcomes is unclear. Purpose To evaluate the associations of cumulative RC exposure and RC variability with incident cardiovascular disease (CVD) in a large, community-based longitudinal cohort. Methods Adults aged ≥30 years from the Tehran Lipid and Glucose Study with ≥2 RC measurements during a median exposure time of 6.1 years, were included. RC was calculated as total cholesterol minus HDL-C minus LDL-C (estimated via Martin–Hopkins). Cumulative RC exposure was assessed using: (1) cumulative RC (average of two consecutive measurements multiplied by the time interval), and (2) cumulative RC burden (weighted sum of differences between phase-specific average RC and predefined cutoffs). RC variability was quantified using standard deviation (SD), and variability independent of the mean (VIM). The primary outcome was CVD, defined as a composite of coronary heart disease (CHD) and stroke. Cox models with progressive adjustment for demographic, clinical, and lifestyle factors, including LDL-C, HDL-C, diabetes, eGFR, BMI, waist circumference, blood pressure, smoking, physical activity, education, marital status, antihypertensive and lipid-lowering medications, were applied. Multiple imputation addressed missing data. Results Among 5,805 participants (mean age 52.6 years; 63% women) during a median follow-up of 10.1 years after exposure period, higher cumulative RC was independently associated with increased CVD risk. Compared with Q1, Q2–Q4 showed progressively higher risk (28%, 47%, and 31% increases; p-trend = 0.039). Cumulative RC burden was similarly associated with CVD [HR 1.27 (1.08–1.51)]. Additionally, greater RC variability (estimated by SD), was also independently associated with CVD risk [HR 1.07 (1.00-1.15)]. Moreover, there was a trend of increased risk across quartiles of SD (p-trend=0.029), with participants in the highest quartile (Q4) of SD having markedly higher risk of CVD [HR 1.31 (1.04-1.65)]. Baseline BMI and PREVENT risk score modified the cumulative RC–CVD relationship, with stronger associations in individuals with BMI ≥30 kg/m2 and 10-year PREVENT risk score <7.5% (p-interaction = 0.013 and 0.007). Restricted cubic spline analyses did not provide evidence of departure from linearity (P for non-linearity = 0.098, and 0.296, respectively) (Figure 1). Conclusion Long-term cumulative RC exposure and RC variability are independently associated with incident CVD, beyond traditional risk factors. Incorporating cumulative and variability metrics may improve early identification of individuals at increased cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Abdi et al. (2026) conducted a cohort in Incident cardiovascular disease (CVD) (n=5,805). Cumulative remnant cholesterol (RC) exposure and RC variability vs. Lower cumulative RC exposure and variability was evaluated on Cardiovascular disease (CVD), defined as a composite of coronary heart disease (CHD) and stroke (HR 1.27, 95% CI 1.08-1.51). Higher cumulative remnant cholesterol burden was independently associated with an increased risk of incident cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: